EsoHot-L
Composition:
- Esomeprazole Magnesium Trihydrate IP Eqv. to Esomeprazole (As EC Pellets) 40 mg
- Levosulpiride 75 mg (As SR Pellets)
Packing: 1x15 Capsule
About the Formulation
EsoHot-L is a fixed-dose gastrointestinal combination containing Esomeprazole 40 mg as enteric-coated (EC) pellets and Levosulpiride 75 mg as sustained-release (SR) pellets. It combines potent gastric acid suppression with prokinetic activity to help manage acid-related disorders associated with impaired gastrointestinal motility.
Indication / Uses
Used in the management of GERD, acid-related dyspepsia, heartburn, and gastrointestinal disorders associated with delayed gastric emptying and impaired gastrointestinal motility.
Mechanism of Action (MOA)
Esomeprazole inhibits the H⁺/K⁺-ATPase proton pump in gastric parietal cells, reducing gastric acid secretion. Levosulpiride acts mainly as a dopamine D₂-receptor antagonist, enhancing gastrointestinal motility and promoting gastric emptying. Together, they help control gastric acidity and improve gastrointestinal motility.
Duration of Use: As prescribed by physician/ respective specialist
Category: Symbiotic Lifesciences
